Macular Degeneration Completed Phase 2 Trials for Aflibercept (DB08885)

Back to Macular Degeneration

Also known as: Macula lutea degeneration / Retinal macula lutea degeneration / Macular luteal degeneration / Degenerative disorder of macula (disorder) / Degeneration macular

IndicationStatusPhase
DBCOND0027875 (Macular Degeneration)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00320788
Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)Treatment
NCT00527423
Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMDTreatment